. 2023 Mar 24;22(5):1492–1500. doi: 10.1021/acs.jproteome.3c00054

Table 1. Number of Unique Reference and Variant Peptides in Canonical Proteins, Alternative Proteins, and Novel Isoforms in 16 Patients with Acute Myeloid Leukemia^a.

	Peptides derived from canonical proteins		Peptides derived from alternative proteins		Peptides derived from novel isoforms
Patients	Total	Variants	Total	Variants	Total	Variants
05H143	45895	143	607	26	21	4
05H149	27771	73	463	11	10	9
07H063	45504	145	612	14	23	2
07H122	46882	181	545	14	12	3
07H141	33691	111	486	18	13	2
08H039	31784	91	384	7	8	2
08H053	33801	93	397	10	7	6
11H008	25517	61	252	8	9	1
11H035	32586	95	467	10	13	3
12H172	43334	129	527	28	17	5
15H013	32250	32	342	3	14	2
15H023	40593	135	404	10	18	1
15H063	31231	94	322	4	13	3
15H080	43293	153	449	14	25	2
16H123	35204	103	471	19	13	3
16H145	46346	183	612	15	25	3

Peptide level FDR 1%.

Table 1. Number of Unique Reference and Variant Peptides in Canonical Proteins, Alternative Proteins, and Novel Isoforms in 16 Patients with Acute Myeloid Leukemiaa.